Alexandria A. Ratzki‐Leewing
机构:Western University, University of Maryland, Baltimore, Foundation for the National Institutes of Health · ORCID:0000-0002-9474-7900
发表论文 75 篇 · 总被引 613 次 · h-index 10
代表论文
- Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus ( iNPHORM , United States) (2023 · Diabetes Obesity and Metabolism · 被引 21)
- FRONTIER : FReeStyle Libre system use in Ontario among people with diabetes in the IC / ES database—Evidence from real‐world practice: Patients on basal insulin, glucagon‐like peptide 1 receptor agonist or oral therapies (2025 · Diabetes Obesity and Metabolism · 被引 9)
- Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024 (2025 · JMIR Infodemiology · 被引 6)
- Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes (2025 · Diabetes Obesity and Metabolism · 被引 5)
- Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States) (2023 · Diabetes Obesity and Metabolism · 被引 5)
- Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US) (2023 · Diabetes Therapy · 被引 5)